Fulton Breakefield Broenniman LLC Baxter International Inc Transaction History

Fulton Breakefield Broenniman LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	BUY	$63.83 - $80.0 $8.02 Million - $10 Million	125,621 New	125,621 $8.07 Million
Q1 2022 Apr 27, 2022	SELL	$76.85 - $89.45 $10 Million - $11.7 Million	-130,583 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$74.57 - $87.19 $86,352 - $100,966	-1,158 Reduced 0.88%	130,583 $11.2 Million
Q3 2021 Oct 25, 2021	SELL	$73.77 - $83.61 $772,371 - $875,396	-10,470 Reduced 7.36%	131,741 $10.6 Million
Q2 2021 Jul 27, 2021	BUY	$80.5 - $88.01 $140,553 - $153,665	1,746 Added 1.24%	142,211 $11.4 Million
Q1 2021 Apr 09, 2021	BUY	$76.38 - $86.03 $1.61 Million - $1.82 Million	21,105 Added 17.68%	140,465 $11.8 Million
Q4 2020 Jan 14, 2021	SELL	$75.39 - $82.36 $1.59 Million - $1.74 Million	-21,096 Reduced 15.02%	119,360 $9.58 Million
Q3 2020 Oct 20, 2020	BUY	$78.33 - $90.73 $774,840 - $897,501	9,892 Added 7.58%	140,456 $11.3 Million
Q2 2020 Jul 10, 2020	BUY	$78.66 - $94.14 $10.3 Million - $12.3 Million	130,564 New	130,564 $11.2 Million

998

450M

1.97M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $17.5B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Fulton Breakefield Broenniman LLC, based on Form 13F filings with the SEC.

Stay updated on Fulton Breakefield Broenniman LLC with notifications on news.